Related Experiment Video
Updated: May 27, 2026
09:23
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Chagas cardiomyopathy
Maria Carmo Pereira Nunes1,2, Antonio Luiz Pinho Ribeiro3,2, Walderez Dutra4
1Department of Internal Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil mcarmo@waymail.com.br.
Heart (British Cardiac Society)
|May 25, 2026
Summary
Chagas cardiomyopathy, a heart condition from *Trypanosoma cruzi* infection, presents diverse symptoms and requires early detection. Advances in diagnosis and management are crucial for improving patient outcomes globally.
Area of Science:
- Cardiology
- Infectious Diseases
- Parasitology
Background:
- Chagas cardiomyopathy, caused by *Trypanosoma cruzi*, is a major cause of heart failure in Latin America and globally due to migration.
- Its complex pathogenesis involves persistent infection, immune responses, microvascular issues, and fibrosis, leading to varied clinical presentations.
Purpose of the Study:
- To provide a comprehensive review of Chagas cardiomyopathy.
- To summarize current knowledge on pathophysiology, clinical spectrum, diagnosis, and management.
- To identify key controversies, knowledge gaps, and research priorities.
Main Methods:
- Literature review of current evidence on Chagas cardiomyopathy.
- Synthesis of information on disease mechanisms, clinical manifestations, diagnostic approaches, and treatment strategies.
- Identification of challenges in early detection and recommendations for future research.
Main Results:
- Chagas cardiomyopathy has a heterogeneous clinical spectrum with four main phenotypes: subclinical, arrhythmic, heart failure, and thromboembolic.
- Diagnosis involves serological confirmation of *T. cruzi* infection, with ECG and echocardiography for cardiac assessment.
- Management includes antiparasitic therapy in early stages and guideline-directed care for heart failure and arrhythmias in established disease.
Conclusions:
- Early detection of Chagas cardiomyopathy, especially in non-endemic areas, remains a significant challenge.
- Strengthening screening, improving access to diagnostics, and implementing multidisciplinary care are vital for better outcomes.
- Further research is needed to address knowledge gaps and advance patient care.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...